Obesity and metabolic syndrome reflect the dysregulation of molecular pathways that control energy homeostasis. Here, we show that the p75 neurotrophin receptor (p75 NTR ) controls energy expenditure in obese mice on a high-fat diet (HFD). Despite no changes in food intake, p75 NTR -null mice were protected from HFD-induced obesity and remained lean as a result of increased energy expenditure without developing insulin resistance or liver steatosis. p75 NTR directly interacts with the catalytic subunit of protein kinase A (PKA) and regulates cAMP signaling in adipocytes, leading to decreased lipolysis and thermogenesis. Adipocyte-specific depletion of p75 NTR or transplantation of p75 NTR -null white adipose tissue (WAT) into wild-type mice fed a HFD protected against weight gain and insulin resistance. Our results reveal that signaling from p75 NTR to cAMP/PKA regulates energy balance and suggest that non-CNS neurotrophin receptor signaling could be a target for treating obesity and the metabolic syndrome.
NTR -null mice were protected from HFD-induced obesity and remained lean as a result of increased energy expenditure without developing insulin resistance or liver steatosis. p75
NTR directly interacts with the catalytic subunit of protein kinase A (PKA) and regulates cAMP signaling in adipocytes, leading to decreased lipolysis and thermogenesis. Adipocyte-specific depletion of p75 NTR or transplantation of p75 NTR -null white adipose tissue (WAT) into wild-type mice fed a HFD protected against weight gain and insulin resistance. Our results reveal that signaling from p75 NTR to cAMP/PKA regulates energy balance and suggest that non-CNS neurotrophin receptor signaling could be a target for treating obesity and the metabolic syndrome.
INTRODUCTION
Obesity, and the ensuing metabolic syndrome characterized by type 2 diabetes, hepatic steatosis, and atherosclerosis, is a worldwide epidemic that increases morbidity and mortality. Obesity develops when energy intake chronically exceeds energy expenditure (Spiegelman and Flier, 2001 ). While many factors control weight gain, glucose, and lipid metabolism (O'Rahilly and Farooqi, 2006) , the molecular mechanisms that dysregulate energy balance remain poorly understood. By understanding these mechanisms, we can develop treatments for obesity and its comorbidities. Studies on energy intake have identified several pathways that control appetite and hypothalamic functions, including leptin, neuropeptide Y, and melanocortin receptors (Spiegelman and Flier, 2001) . Intriguingly, neurotrophin activation of cognate tyrosine kinase (Trk) receptors correlates with hypothalamic suppression of appetite control. Indeed, brain-derived neurotrophic factor (BDNF) signals through TrkB in the hypothalamus to suppress appetite and reduce body weight (Lyons et al., 1999; Xu et al., 2003b) . On a normal diet, BDNF +/À mice (Lyons et al., 1999) or mice conditionally depleted of BDNF in neurons (Xu et al., 2003b) overeat and become obese. These results suggest that neurotrophin receptor signaling affects how the CNS controls energy intake and body weight.
Neurotrophins and their receptors are also expressed in several peripheral metabolic tissues, suggesting that non-CNS molecular networks might regulate energy expenditure. Here, we report that loss of p75 neurotrophin receptor (p75 NTR ) protects mice from obesity and the metabolic syndrome. p75 NTR regulates energy expenditure and thermogenesis, and its adipocyte-specific depletion reduces obesity. These findings suggest that manipulating non-CNS functions of p75 NTR signaling could provide a new therapeutic approach for obesity and the metabolic syndrome.
RESULTS

p75
NTR Knockout Mice Are Resistant to HFD-Induced Obesity, Insulin Resistance, and Hepatic Steatosis p75 NTR is widely expressed in metabolic tissues, including liver (Cassiman et al., 2001; Passino et al., 2007) , white adipose tissue (WAT) (Baeza-Raja et al., 2012; Peeraully et al., 2004) , and skeletal muscle (Deponti et al., 2009 ), but we do not know whether it affects obesity. p75 NTR expression increased in WAT after 3 weeks of a high-fat diet (HFD), but not in skeletal muscle or liver ( Figure 1A ). p75 NTR was also highly expressed in differentiated 3T3L1 adipocytes and mouse embryonic fibroblast (MEF)-derived adipocytes ( Figure S1A ). To evaluate whether p75 NTR affects obesity, p75 NTRÀ/À mice were placed on a HFD and compared to their wild-type (WT) littermates. Interestingly, p75 NTRÀ/À mice were resistant to weight gain and remained lean after several weeks on a HFD compared to controls (Figures 1B and S1B) . p75 NTRÀ/À mice also showed reduced adiposity, fat volume, and total weight of inguinal and intraperitoneal fat pads ( Figures 1C and 1D ). Weight did not differ between p75 NTR+/À and WT mice on a HFD ( Figure S1C ). Adipocytes were 4-fold larger in control than in p75 NTRÀ/À fat pads from mice on a HFD ( Figure S1D ). After just 3 weeks on a HFD, adipocytes in WT mice were enlarged, while epididymal fat from p75 NTRÀ/À mice contained smaller adipocytes ( Figure S1E ). Obesity is a key trigger for type 2 diabetes, so we explored whether p75 NTRÀ/À mice are protected from insulin resistance.
Basal insulin levels were 3-fold higher in WT than in p75 NTRÀ/À mice on a HFD ( Figure 1E ). p75 NTRÀ/À mice also displayed increased insulin sensitivity, markedly improved glucose tolerance, and enhanced glucose lowering effects of insulin ( Figures  1F, 1G , and S1F). With the hyperinsulinemic-euglycemic clamp technique, we found that glucose infusion rates were higher in p75 NTRÀ/À mice than in WT mice on a HFD ( Figure 1H ), demonstrating improved systemic insulin sensitivity. Furthermore, tracer-derived Rd or glucose disposal rate (GDR) and insulinstimulated GDR were higher in p75 NTRÀ/À mice ( Figure 1I ), indicating increased muscle insulin sensitivity. Basal hepatic glucose production (HGP) did not change in p75 NTRÀ/À mice, but insulin-induced suppression of HGP increased from 40% to 64% (Figures S1G and S1H) , showing decreased hepatic insulin resistance induced by a HFD. (F and G) Glucose tolerance (F) and insulin tolerance (G) tests in WT (n = 13) and p75 NTRÀ/À (n = 8) mice after 20 weeks on HFD. *p < 0.05; **p < 0.01; ***p < 0.001, two-way ANOVA.
(H) Glucose infusion rates from WT (n = 5) and p75 NTRÀ/À (n = 7) mice on an HFD. *p < 0.05, unpaired Student's t test.
(I) Total and insulin-stimulated GDRs of WT (n = 5) and p75 NTRÀ/À (n = 7) mice on an HFD. *p < 0.05, unpaired Student's t test.
(J) Representatives photographs (top) and histological images (bottom) of livers from WT and p75 NTRÀ/À mice on an HFD (n = 3 mice per group).
Data are shown as means ± SEM. See also Figures S1 and S2.
HFD triggers non-alcoholic fatty liver disease, which can cause liver steatosis, cirrhosis, and hepatocellular cancer (Osterreicher and Brenner, 2007) . After 16 weeks on a HFD, control mice developed and massively accumulated hepatic lipids and had increased liver weight, as expected, while p75 NTRÀ/À mice were protected (Figures 1J and S2A) . Livers from p75 NTRÀ/À mice on a HFD did not have higher levels of Sterol Regulatory ElementBinding Protein 1 (SREBP-1) ( Figure S2B ), a transcription factor that drives lipogenesis and molecularly marks liver steatosis (Shimomura et al., 1999) . Liver triglycerides, SREBP-1 target genes, fatty-acid-uptake genes, and fatty-acid-oxidation genes were reduced in p75 NTRÀ/À mice compared to WT mice on a HFD (Figures S2C and S2D) . Moreover, p75 NTRÀ/À mice were protected from increased cholesterol and HFD-induced inflammation in WAT ( Figures S2E and S2F ). These results demonstrate that loss of p75 NTR protects against obesity and the metabolic syndrome.
Loss of p75 NTR Increases Energy Expenditure and Fat Oxidation Food consumption and energy intake normalized to lean mass were similar in WT and p75 NTRÀ/À mice (Figure 2A ), suggesting that the lean phenotype of p75 NTRÀ/À mice might be due to changes in energy expenditure and not appetite. Indeed, total oxygen consumption and energy expenditure were dramatically increased in p75 NTRÀ/À compared to WT mice ( Figure 2B ), despite similar activity levels ( Figure S3A ). CO 2 production was also greater in p75 NTRÀ/À mice ( Figure S3B ). Increased energy expenditure was confined to fat oxidation (Figures 2C and S3C) . Given that WAT regulates systemic energy (Rosen and Spiegelman, 2014) , we analyzed fat oxidation and thermogenesis in adipocytes. Isolated adipocytes from p75 NTRÀ/À mice had 2.4-fold higher fat oxidation than those from WT mice ( Figure 2D ), and 3-fold and 4-fold higher uncoupling protein 1 (Ucp1) and deiodonase-2 (Dio2) expression, respectively ( Figure 2E ). Peroxisome proliferator-activated receptors (Ppars) d and g (Ppard and Pparg, respectively) and Ucp2 were unaffected (data not shown). Ucp1 protein and RNA, Ppard coactivator-1a (Pgc-1a), and Ppara gene expression were increased in p75 NTRÀ/À WAT ( Figures S3D and S3E ). After cold exposure, core body temperatures were elevated in p75 NTRÀ/À mice ( Figure S3F ). Adiponectin, an adipocyte-derived hormone that increases fat oxidation (Fruebis et al., 2001 ) and correlates inversely with insulin resistance (Kadowaki et al., 2006) , was higher in serum from p75 NTRÀ/À mice after HFD ( Figure 2F ). These results are consistent with increased fat oxidation in p75 NTRÀ/À adipocytes (Figure 2C ) and insulin sensitivity in p75 NTRÀ/À mice ( Figures 1E-1I and S1F-S1H). Adipocyte differentiation markers and lipid accumulation were similar between WT and p75 NTRÀ/À adipocytes ( Figures S4A and S4B ), suggesting that decreased adipogenesis was not due to impaired adipocyte differentiation in p75 NTRÀ/À mice. Decreased adipogenesis was also not due to altered lipogenesis capacity, as expression of lipogenic genes, including fatty acid synthase (Fas) and diglyceride acyl-transferase-1 (Dgat1), was not affected ( Figure S4C ). In brown adipose tissue (BAT), p75 NTR expression did not increase with HFD ( Figure S4D ). Expression of thermogenic genes, fat oxidation, and molecular markers for brown adipocytes were also not different between BAT from WT and p75 NTRÀ/À mice on a HFD ( Figure S4E) mice on a HFD ( Figure S5D ). Isoproterenol increased FFA release by $1.6-fold and $2.5-fold in WT and p75 NTRÀ/À WAT, respectively ( Figure S5B ), similar to prior studies (Jaworski et al., 2009 ). Neurotrophins did not affect FFA secretion in WT or p75 NTRÀ/À WAT ( Figure S5E ), suggesting that lipolysis is a neurotrophin-independent function. Signaling through the cyclic AMP (cAMP)/protein kinase A (PKA) pathway primarily regulates lipolysis (Zechner et al., 2012) . We found that lipolysis and cAMP levels were significantly higher in p75 NTRÀ/À compared to WT WAT on a HFD (Figures 3A and 3B) but not on normal chow (Figures 3B and S5F (Haemmerle et al., 2002; Osuga et al., 2000) . We found that phosphorylated HSL (P-HSL) was increased in p75 NTRÀ/À WAT and MEF-derived adipocytes (Figures 3D and S5G) . Hsl gene expression was increased by $1.8-fold ( Figure S5H ), but HSL protein was not significantly increased in p75 NTRÀ/À WAT ( Figure 3D ) and MEF-derived adipocytes ( Figure S5G ). Phosphorylation of other PKA targets, including perilipin, cAMP response element-binding protein (CREB) (P-CREB), and p38 (P-p38), were also increased in p75 NTRÀ/À WAT ( Figure 3D ) and MEF-derived adipocytes ( Figure S5G ). These results support that p75 NTR regulates lipolysis by modulating cAMP/PKA signaling and catecholamine sensitivity.
NTR Directly Binds the Regulatory and Catalytic PKA Subunits and Regulates PKA Holoenzyme Dissociation Dissociation of the PKA subunits is a critical step for PKA activation . To explore how p75 NTR regulates cAMP/ PKA signaling, we examined whether p75 NTR regulates the tetrameric PKA holoenzyme by studying the interaction between the catalytic (Ca) and regulatory (RIIb) PKA subunits. Intriguingly, the Ca subunit was dissociated from RIIb in p75 NTRÀ/À MEF-derived adipocytes ( Figure 3E ), despite no differences in protein expression of PKA subunits ( Figure 3F ). These results indicate that p75 NTR deletion causes constitutive dissociation and activation of the PKA catalytic subunit, which agrees with increased cAMP levels ( Figure 3B ), lipolysis (Figures 3A and S5B) , and HSL phosphorylation (Figures 3D and S5G) in p75 NTRÀ/À adipocytes. p75
NTR bound both Ca and RIIb when co-immunoprecipitated from overexpression systems ( Figure 3G ) and endogenously in WAT ( Figure 3H ). In binding assays, the intracellular domain of p75 NTR (p75ICD) directly interacted with both Ca and RIIb, but not with the unrelated protein Hsp20 ( Figure 3I ). Screening an array library of overlapping p75ICD 25-mer peptides revealed that Ca and RIIb bound within helix 5 (peptides 16-21, amino acids [aa] 348-397) and helix 6 (peptides 23-25, aa 383-417) of the death domain (DD) of p75ICD, respectively ( Figure 4A ). An alanine scanning substitution array of p75ICD identified key residues that enable its interaction with Ca (residue C379) and RIIb (residues P380, R382, L385, R404, R405, and R408) (Figures 4B and 4C) . Thus, we performed site-specific mutagenesis of p75 NTR ( Figure 4D ) and found that the C379A mutation abolished its interaction with Ca, while mutations of the other residues for RIIb abolished its interaction with RIIb (Figures 4E and 4F) . These results support the finding that p75 NTR directly interacts with PKA subunits through motifs within its DD. Next, we tested in adipocytes the interaction of p75 NTR with cAMP-degrading phosphodiesterases (PDEs) and the functional consequences of p75 NTR mutants that disrupt the interaction of p75 NTR with PKA subunits. Consistent with our prior study (Sachs et al., 2007) , p75 NTR co-immunoprecipitated with cAMP-hydrolyzing enzyme phosphodiesterase 4A5 (PDE4A5) in WAT and adipocytes ( Figure S6A ). Lentiviral expression of WT p75 NTR or p75 NTR C379A reduced P-HSL levels in p75 NTRÀ/À MEF-derived adipocytes by $2-fold and $1.5-fold, respectively ( Figure 4G ). Expression of the p75 NTR 2M mutant, which reduces binding of p75 NTR to PKA-RIIb, did not alter P-HSL ( Figure 4G ). We performed these analyses with isoproterenol ( Figure 4G ), because at baseline, control lentivirus increased basal levels of P-HSL ( Figure S6B ). Lentiviral expression of both WT p75 NTR and p75 NTR C379A reduced cAMP levels ( Figure S6C ), suggesting that p75 NTR regulates cAMP/PKA signaling through multiple pathways. ) (Bogenmann et al., 2011 ) with aP2-cre (Adipocyte-cre) mice, which show gene recombination specifically in adipocytes without gene recombination in brain, muscle, liver, stromal vascular cells, and macrophages (Ahmadian et al., 2011; Barak et al., 2002; He et al., 2003; Lee et al., 2014; Li et al., 2011; Paschos et al., 2012; Qi et al., 2009) . In p75 AKO mice, p75 NTR was specifically deleted in adipose tissue and not the brain and muscle (Figures 5A and 5B) . Strikingly, p75 AKO mice weighed significantly less ( Figure 5C ) and showed improved glucose and insulin tolerance ( Figure 5D ), suggesting that specifically deleting p75 NTR from adipose tissue protects against diet-induced obesity and type 2 diabetes. In addition, livers from p75 AKO mice on a HFD showed reduced SREBP-1 and hepatic lipid accumulation compared to WT mice ( Figures S7A and S7B ). In contrast, muscle-specific knockout mice (p75 SKMKO ) had weight gain similar to that of p75 F/F and muscle creatine kinase (MCK)-cre (SKM-cre) control mice ( Figures 5E and 5F ). These results support the reduced body weight gain and increased insulin sensitivity in p75 NTRÀ/À mice on a HFD, demonstrating that deleting p75
NTR from adipocytes protects against HFD-induced obesity and insulin resistance. p75 AKO mice showed increased energy expenditure and fat oxidation, despite similar activity and no changes in food WAT isolated from p75 AKO mice showed increased metabolic rates via increased expression of thermogenic, brown adipose identity, and lipolytic genes such as Dio2, Ucp-1, Pgc-1a, Ppara, and Hsl ( Figure 6D ). HSL phosphorylation was also increased in WAT of p75 AKO compared to control mice ( Figure 6E ). These results indicate that adipose-specific expression of p75 NTR is a major contributor to obesity, energy expenditure, and lipolysis.
To further analyze the adipose-specific role of p75 NTR in vivo, we transplanted epididymal fat pads from p75 NTRÀ/À mice into the visceral area of WT (p75 NTRÀ/À / WT) mice ( Figure 7A ).
After 6 weeks on a HFD, the increase in body weight was significantly lower in p75 NTRÀ/À / WT compared to WT / WT WAT or sham-operated controls ( Figure 7B ). p75 NTRÀ/À / WT mice also showed improved glucose and insulin tolerance 10 weeks after a HFD ( Figure 7C ). Insulin sensitivity was unaffected in WT / WT or sham-operated mice ( Figure 7C ), as expected (Tran et al., 2008) . The effect of p75 NTRÀ/À WAT transplantation on body weight and insulin sensitivity on WT mice is significant, and the values obtained are at a range similar to that observed in other transplant studies (Chen et al., 2003; Minamino et al., 2009 
DISCUSSION
Many studies have addressed the key mechanisms in adipocytes that regulate energy balance, but the molecular links between diet, energy storage and mobilization, and signaling remain unclear. While studies have shown that neurotrophins and their receptors regulate appetite (Lyons et al., 1999; Xu et al., 2003b) , we report a surprising role for the neurotrophin receptor p75 NTR in adipose tissue. We found that p75 NTR is upregulated in adipocytes after a HFD, where it directly suppresses PKA activity to attenuate lipolysis, fat oxidation, and thermogenesis and renders adipose tissue resistant to catecholamine stimulation. Although p75 NTRÀ/À mice did not show differences in appetite or physical activity, they were protected against diet-induced weight gain, type 2 diabetes, atherosclerosis, inflammation, and hepatic steatosis, suggesting that p75 NTR regulates obesity and its comorbidities. In cell-autonomous systems, p75 NTR did not affect fat cell differentiation, which further supports its specificity in regulating cAMP/PKA signaling and thermogenesis. Additionally, specifically depleting p75 NTR in adipocytes protected mice from HFD-induced obesity and insulin resistance. In contrast, loss of BDNF and TrkB regulate body weight by increasing appetite on normal chow (Lyons et al., 1999; Xu et al., 2003b) . Therefore, the metabolic outcome of neurotrophin receptor signaling in vivo may depend on the balance between neurotrophin-dependent central regulation of , Adipocyte-cre, and p75 AKO mice (n = 5 mice per group). Representative blot is shown.
(B) p75 NTR expression in brain, WAT (epididymal fat), SUBC (subcutaneous inguinal fat), BAT, Soleus (skeletal muscle), kidney, and heart from Adipocyte-cre and p75 AKO mice (n = 5 mice per group).
(C) Body weight of p75 F/F (n = 18), Adipocyte-cre (n = 7), and p75 AKO (n = 10) mice on a HFD. **p < 0.01; ***p < 0.001, two-way ANOVA.
(D) Glucose (left) and insulin tolerance (right) tests in Adipocyte-cre (n = 7) and p75 AKO (n = 10) mice after 8 weeks on a HFD. *p < 0.05; **p < 0.01; ***p < 0.001, twoway ANOVA. (E) p75 NTR protein expression in skeletal muscle from p75 F/F (n = 3), SKM-cre (n = 2), and p75 SKMKO mice (left) (n = 3). Quantifications of western blot analysis for p75 NTR in skeletal muscle from p75
, SKM-cre, and p75 SKMKO mice (right). **p < 0.01, Tukey's multiple comparisons test and one-way ANOVA; ns, not significant. (F) Body weight of p75 F/F (n = 18), SKM-cre (n = 10), and p75 SKMKO (n = 15) mice on a HFD (ns, not significant, two-way ANOVA).
Data are shown as means ± SEM. See also Figure S7 .
food intake by BDNF/TrkB signaling and neurotrophin-independent peripheral regulation of energy expenditure in fat by p75 NTR . (Cummings et al., 1996; Schreyer et al., 2001 ). In mice, it induces a compensatory increase in the RIa subunit, generating a tetrameric holoenzyme that binds more avidly to cAMP (Cummings et al., 1996) . In contrast, we showed that deleting p75 NTR causes dissociation of the PKA subunits without affecting the levels of RIa. These results suggest that changes in both the levels of the PKA subunits and modifications of the conformation of the PKA holoenzyme might control the lipolytic pathway in adipocytes. Triggering b-adrenergic receptors in adipocytes stimulates energy expenditure by cAMP-dependent increases in lipolysis and fatty-acid oxidation (Song et al., 2010) . Our study shows similar effects between isoproterenol-stimulated and p75 NTRÀ/À adipocytes, suggesting that loss of p75 NTR increases cAMP and lipolysis. Thus, the interaction between p75 NTR and PKA regulates the formation of the PKA holoenzyme, and p75 NTR deletion increases cAMP levels, constitutive PKA dissociation, lipolysis, and energy expenditure. Interestingly, feedback mechanisms reciprocally link cAMP levels and PKA activity-PKA phosphorylation can inhibit adenylyl cyclases and increase PDE4 activity (Iwami et al., 1995; MacKenzie et al., 2002) lor et al., 2012) . Similar to p75 NTR , A-kinase anchoring proteins (AKAPs) directly bind PKA and PDEs to compartmentalize cAMP/PKA signaling by associating with target effectors, substrates, and signal termination (Baillie et al., 2005; Carr et al., 1991; Dodge-Kafka et al., 2005) . Canonical AKAPs are characterized by the specific amphipathic helix of 14-18 aa that bind PKA subunits ( does not contain the AKAP amphipathic helix, p75 NTR might function as a non-conventional AKAP-regulating PKA signal by directly binding both PKA subunits and PDEs. Moreover, given that regulation of PKA is critical in metabolism and neuronal functions, p75 NTR might regulate cAMP/PKA signaling in neuronal cells (Zhong et al., 2009) . Structural biology studies are needed to understand the PKA holoenzymes and macromolecular assemblies that regulate cAMP/PKA signaling (Kim et al., 2007; Zhang et al., 2012) . These studies will determine the contribution of a potential PDE4A-p75 NTR -PKA macromolecular complex in cAMP regulation and will characterize the properties of p75 NTR as a ''non-conventional'' AKAP in peripheral tissues and the brain. p75 NTRÀ/À mice were protected against HFD-induced insulin resistance through significantly enhanced insulin sensitivity in skeletal muscle, hepatic, and adipose tissue. Since p75 NTRÀ/À mice remain lean on HFD, their resistance to type 2 diabetes could be a secondary effect to reduced body weight. Increased insulin sensitivity in p75 NTRÀ/À mice on normal chow (Baeza-Raja et al., 2012) might also contribute to reduced insulin resistance upon HFD. p75 AKO mice and p75 NTRÀ/À / WT mice showed increased systemic insulin sensitivity after HFD, emphasizing the primacy of WAT in systemic insulin regulation and its communication with other key metabolic organs to enhance insulin sensitivity. In this regard, p75 NTRÀ/À mice showed substantial increases in circulating levels of adiponectin, an adipocyte-derived hormone that reduces insulin resistance and liver steatosis by increasing fat oxidation via the AMP-activated protein kinase pathway (Fruebis et al., 2001; Xu et al., 2003a) . Increased lipolysis induces fatty acid oxidation. Thus, potential increases in oxidation could also be interpreted as consequences of increased lipolysis. For example, reciprocal regulation of lipolysis and fat oxidation associated with crosstalk between the cAMP/PKA pathway and Sirt-1 regulates fatty acid oxidation (Gerhart-Hines et al., 2011) . Our study shows that p75 NTR does not regulate adipocyte differentiation, which supports prior studies showing that defects in lipolysis do not affect adipocyte differentiation. For example, similar to p75 NTRÀ/À mice, adipose-specific phospholipase A 2 (AdPLA) knockout adipocytes showed normal intracellular lipid accumulation and significantly increased lipolysis (Jaworski et al., 2009 ). *p < 0.05; **p < 0.01; ***p < 0.001, two-way ANOVA. n = 4 mice per group. Data are shown as means ± SEM. fatty acids, suggesting that increased fatty acid oxidation protects p75 NTRÀ/À mice from increased lipolysis. Indeed, adipocytes can increase FFA use and energy expenditure without increasing serum fatty acid levels ). Thus, weight reduction and increased lipid oxidation might be due, in part, to increased synthesis of adiponectin or other adipokines or metabolites derived from WAT. While glucose tolerance significantly improved in p75 AKO and p75 NTRÀ/À / WT mice 8 weeks after HFD, it was reduced compared to p75 NTRÀ/À mice tested 20 weeks after HFD. These differences may be due to effects of p75 NTR expression in tissues other than adipose tissue or to different time points used to measure glucose tolerance.
Our study shows increased P-HSL in WAT isolated from p75 NTRÀ/À ( Figure 3D ) and p75 AKO mice ( Figure 6E ), and in p75 NTRÀ/À MEF-derived adipocytes cultured in vitro (Figure S5G) , indicating that p75 NTR loss similarly increases P-HSL in WAT and MEF-derived adipocytes. As expected, the relative fold changes are different between tissue isolated from mice ( Figure 3D ) and cultured cells ( Figure S5G ). The $1.8-fold and $2.3-fold increases in Hsl RNA in p75 NTRÀ/À WAT ( Figure S5H ) and p75 AKO mice ( Figure 6D ), respectively, did not change total HSL protein. These results further suggest that p75 NTR contributes to PKA-mediated phosphorylation of HSL ( Figures 3D  and 6E ) and are consistent with prior studies showing that HSL is primarily regulated post-translationally (Kraemer and Shen, 2002) . We also found$7-fold and $2.5-fold increases in P-HSL in WAT isolated from p75 AKO and control Adipocyte-Cre mice, respectively. Since phosphorylation of HSL in vivo depends on fasting conditions (Kraemer and Shen, 2002) , variability in P-HSL within animals may be due to their responses to fasting. Regardless of the expected variability of signal transduction in vivo, the increase in P-HSL in p75 AKO mice supports the data obtained in vivo in p75 NTRÀ/À mice and in vitro in p75 NTRÀ/À MEF-derived adipocytes showing that p75 NTR depletion in fat increases HSL phosphorylation. We also evaluated PKA-mediated phosphorylation of perilipin by pulling down perilipin and blotting with P-PKA (Choi et al., 2010; Marcinkiewicz et al., 2006) . Our study tested phosphorylation of all six potential PKA phosphorylation sites on perilipin (Greenberg et al., 1993; Zhang et al., 2003) . Future studies will map the potential specific phosphorylation sites of perilipin that are regulated by p75 NTR . however, p75 NTR also contributes to many signaling pathways and biological functions independent of ligands (Barker, 2004; Teng and Hempstead, 2004; Zampieri and Chao, 2006) . For example, p75 NTR can serve as a co-receptor for receptors other than neurotrophins, such as the Nogo receptor and ephrin-As (Domeniconi et al., 2005; Lim et al., 2008; Wong et al., 2002) . p75 NTR can also induce signaling independent of neurotrophins and/or function as a co-receptor. Prior studies suggested that p75 NTR may signal in a neurotrophin-independent manner in neuronal cells to induce apoptosis (Majdan et al., 1997; Rabizadeh et al., 1993) and activate PI3 kinase (Roux et al., 2001) , RhoA (Yamashita et al., 1999) , PDE4A (Sachs et al., 2007) , hypoxia inducible factor (HIF)-1a (Le Moan et al., 2011) , and transforming growth factor (TGF)-b (Schachtrup et al., 2015) . In these studies, expressing p75ICD alone could exert a signaling event and biological effect without a neurotrophin ligand. Moreover, crosslinking of p75 NTR dimers constitutively activates several pathways independent of ligands (Vilar et al., 2009) . Since p75 NTR is not constitutively expressed but is upregulated upon a HFD, its expression could trigger activation of a signaling pathway. Since tumor necrosis factor (TNF)-a and interleukin (IL)-1b induce p75 NTR expression, increased pro-inflammatory activity upon HFD might augment p75 NTR levels ). There are several examples of well-established ligand-independent signaling pathways in other receptor systems. For example, steroid hormone receptors (Power et al., 1991) , scavenger receptors (Li et al., 2005) , viral G-protein-coupled receptors (Vischer et al., 2006) , androgen receptors (Culig, 2004) , and B cell receptors (Monroe, 2004) all signal in a ligand-independent manner. Future studies will address the potential endogenous mechanisms that increase expression of p75 NTR upon HFD. In prior studies, p75 NTRÀ/À mice have shown many physiological phenotypes, including deficits in sensory nerve development (Lee et al., 1994) , neurogenesis (Young et al., 2007; Zuccaro et al., 2014) , and insulin resistance (Baeza-Raja et al., 2012) . In animal models of disease, p75 NTRÀ/À mice have also shown many pathological phenotypes, such as deficits in oligodendrocyte apoptosis (Beattie et al., 2002) , liver regeneration , retinal hypoxia (Le Moan et al., 2011) , and astrocyte functions (Schachtrup et al., 2015) . Our study identified a fundamental role for p75 NTR in metabolism, given the dramatic resistance of p75 NTRÀ/À mice to diet-induced obesity. Proteins such as p75 NTR , which are expressed in several tissues and control multiple signaling pathways, commonly have pleiotropic biological functions in vivo. For example, many phenotypes have been seen in the brain and peripheral tissues of mice depleted of transcription factors such as nuclear factor kB (NF-kB) and Sirt-1, or scaffold proteins such as b-arrestin. We have shown that p75 NTRÀ/À mice have reduced HIF-1a and are resistant to hypoxia (Le Moan et al., 2011) . Indeed, fat-specific depletion of HIF-1a improves insulin sensitivity and decreases adiposity in HFD-fed mice (Jiang et al., 2011 (Lee et al., 1992) , adipocyte-cre (aP2-cre) (He et al., 2003) , and MCK-cre (Br€ uning et al., 1998) NTRflox/flox ) mice. Male mice 9-25 weeks old were used. Mice were housed under a 12 hr:12 hr light:dark cycle, fed a standard chow or a HFD (60% calories from fat, D12492, Research Diets), and had access to food and water ad libitum. All animal experiments were performed under the guidelines set by the Institutional Animal Care and Use Committee of the University of California, San Francisco, and University of California, San Diego, and are in accordance with the NIH.
Metabolic Cages
The Comprehensive Lab Animal Monitoring Systems (Columbus Instruments) was used to measure food intake, movement, volume of carbon dioxide produced (VCO 2 ), volume of oxygen consumed (VO 2 ), respiration rate (RER = VCO 2 /VO 2 ), and caloric output [(3.815 + 1.232 3 RER) 3 VO 2 ] over 5 consecutive days. Mice were housed in individual cages for 5 days and allowed to acclimate in the recording metabolic chambers for 24 hr before the start of measurements to minimize stress. Mouse weights and body composition were determined before the monitoring period. Body composition was determined by quantitative magnetic resonance on the EchoMRI 3-in-1 body composition analyzer (EchoMRI). Fat and lean mass were determined by the system software. Data were normalized to body weights, except VO 2 and VCO 2 , which were normalized to lean mass. Fat oxidation was calculated using the formula [(1.695 3 VO 2 ) À (1.701 3 VCO 2 )] 3 9. Values were normalized by lean mass. Measurements of energy intake and energy expenditure were averaged over four light and dark periods.
Co-immunoprecipitation
Co-immunoprecipitation was performed as described previously (Le Moan et al., 2011) . Cell lysates were prepared in 1% NP-40, 200 mM NaCl, 1 mM EDTA, and 20 mM Tris-HCl (pH 8.0). Rabbit anti-p75 NTR antibody 9992 (a kind gift from Moses Chao), rabbit anti-PKACa (Cell Signaling), and rabbit anti-perilipin (Cell Signaling) were used for IP, and immunoblots were performed with anti-PKACa, anti-PKARIIa, anti-PKARIIb, anti-PDE4A, anti-phospho PKA substrate, and anti-p75 NTR . Additionally, rabbit anti-HA (hemagglutinin) and mouse anti-Myc were used for IP, and immunoblots were performed with anti-GFP, anti-HA, and anti-Myc.
cAMP, Active PKA, Adiponectin, Triglycerides, and Cholesterol cAMP (Assay Designs) and active PKA (Enzo Life Sciences) were measured following manufacturer's instructions. Forskolin (10 mM; Sigma) was added for 1 hr. Adiponectin in serum was measured by ELISA (B-Bridge International), according to manufacturer's instructions. Liver triglycerides (Abcam) were measured following manufacturer's instructions. Total blood cholesterol was measured using PTS Panels test strips (Polymer Technology Systems) on blood samples collected from animals after fasting.
Statistical Analysis
Statistical significance was calculated with GraphPad Prism (GraphPad Prism Software) by an unpaired two-sided Student's t test to analyze significance between two experimental groups or by non-parametric two-sided Mann-Whitney test, Tukey's multiple-comparisons test, one-way ANOVA, or two-way ANOVA for multiple comparisons followed by a Bonferroni's post-test. Data are shown as means ± SEM. 
